Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56473-96-2

Post Buying Request

56473-96-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56473-96-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 56473-96-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,4,7 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 56473-96:
(7*5)+(6*6)+(5*4)+(4*7)+(3*3)+(2*9)+(1*6)=152
152 % 10 = 2
So 56473-96-2 is a valid CAS Registry Number.

56473-96-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-azidofuran-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names 3-azido-2-formyl-furan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56473-96-2 SDS

56473-96-2Upstream product

56473-96-2Relevant articles and documents

3-Nitrene-2-formylthiophene and 3-Nitrene-2-formylfuran: Matrix Isolation, Conformation, and Rearrangement Reactions

Liu, Jie,Qian, Weiyu,Wang, Lina,Wu, Zhuang,Yang, Yang,Zeng, Xiaoqing

, p. 3786 - 3794 (2020/06/09)

Two new heteroarylnitrenes, 3-nitrene-2-formylthiophene (15/15′) and 3-nitrene-2-formylfuran (16/16′), in the triplet ground state have been generated in solid Ar (10.0 K) and N2 (15.0 K) matrices by the 266 nm laser photolysis of 3-azido-2-formylthiophene (13) and 3-azido-2-formylfuran (14), respectively. According to the characterization with matrix-isolation IR spectroscopy and quantum chemical calculations at the B3LYP/6-311++G(3df,3pd) level, both nitrenes exhibit two conformations depending on the orientation of the formyl groups. Upon subsequent green-light irradiation (532 nm), both the nitrenes 15/15′ and 16/16′ undergo ring closure to form 3,2-thienoisoxazole (17) and 3,2-furoisoxazole (18), respectively. Traces of 3-imino-4,5-dihydrothiophene-2-ketene (19), formally formed through the intramolecular 1,4-H shift in the corresponding nitrenes 15/15′, have been also identified among the laser photolysis products of the azide 13. In sharp contrast to the photochemistry, the high-vacuum flash pyrolysis (HVFP) of the azide 13 at ca. 1000 K mainly yields imino ketene in two conformations 19/19′ together with traces of isoxazole 17. In addition to the reversible conformational interconversion in the imino ketene 19 ? 19′, the photoisomerization from isoxazole 17 to imino ketene 19 has also been observed. The HVFP of the azide 14 at ca. 1000 K results in complete dissociation to HCN, C2H2, CO, CO2, H2O, and N2. Unlike the recently disclosed hydrogen-atom tunneling (HAT) in the transformation from the structurally related 2-formyl phenylnitrene (2) to imino ketene 3 in a cryogenic Ar-matrix, the absence of HAT in nitrenes 15 and 16 can be reasonably explained by the higher barrier heights and also larger barrier widths in the isomerization reactions.

Rigidified Compounds for Modulating Heparanase Activity

-

Page/Page column 63-64, (2010/11/30)

Disclosed are novel rigidified compounds having a rhodanine-like residue and at least one aryl or heteroaryl residue linked to the rhodanine-like residue, whereby a core structure of these compounds, as defined in the specification, is characterized as having one or zero free-to-rotate bonds. Also disclosed are pharmaceutical compositions containing these rigidified compounds and uses thereof for modulating the activity of heparanase and hence in the treatment of heparanase-associated diseases and disorders, and uses thereof for modulating the activity of heparin-binding proteins and hence in the treatment of heparin-binding proteins-associated diseases and disorders as well as in the treatment of medical conditions that are at least partially treatable by rhodanine or a rhodanine analog.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56473-96-2